Covid-19 vaccine highly effective in preventing Covid-19: AstraZeneca
AstraZeneca says late-stage trials of its COVID-19 vaccine were highly
effective'' in preventing disease.
A
vaccine developed by AstraZeneca and the University of Oxford prevented 70% of
people from developing the coronavirus in late-stage trials, the team reported
Monday.
Key
researcher Dr. Andrew Pollard said scientists were pleased with the results. He
said researchers found that if people were given a half dose followed by a full
dose, rather than two full doses, protection rose to about 90%.
These
findings show that we have an effective vaccine that will save many
lives," he said.
Two
other drugmakers, Pfizer and Moderna, last week reported preliminary results from
late-stage trials showing that their COVID-19 vaccines were almost 95%
effective. Read More
Comments
Post a Comment